183 related articles for article (PubMed ID: 20359579)
1. Functional classification of peripheral T-cell lymphomas as an approach to improve outcome prediction and therapy selection.
Jones D
Semin Hematol; 2010 Apr; 47 Suppl 1():S1-4. PubMed ID: 20359579
[TBL] [Abstract][Full Text] [Related]
2. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of peripheral T-cell lymphomas.
O'leary H; Savage KJ
Curr Opin Hematol; 2009 Jul; 16(4):292-8. PubMed ID: 19509496
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis.
Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M
Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433
[TBL] [Abstract][Full Text] [Related]
5. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
Vose J; Armitage J; Weisenburger D;
J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
[TBL] [Abstract][Full Text] [Related]
6. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
7. Peripheral T-cell lymphoma with follicular T-cell markers.
Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
[TBL] [Abstract][Full Text] [Related]
8. Peripheral T-cell lymphomas.
Macon WR
Hematol Oncol Clin North Am; 2009 Aug; 23(4):829-42. PubMed ID: 19577171
[TBL] [Abstract][Full Text] [Related]
9. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
10. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB
Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127
[TBL] [Abstract][Full Text] [Related]
11. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas.
Ballester B; Ramuz O; Gisselbrecht C; Doucet G; Loï L; Loriod B; Bertucci F; Bouabdallah R; Devilard E; Carbuccia N; Mozziconacci MJ; Birnbaum D; Brousset P; Berger F; Salles G; Briére J; Houlgatte R; Gaulard P; Xerri L
Oncogene; 2006 Mar; 25(10):1560-70. PubMed ID: 16288225
[TBL] [Abstract][Full Text] [Related]
13. Aggressive peripheral T-cell lymphomas (specified and unspecified types).
Savage KJ
Hematology Am Soc Hematol Educ Program; 2005; ():267-77. PubMed ID: 16304391
[TBL] [Abstract][Full Text] [Related]
14. [World Health Organization (WHO) classification of malignant lymphoma--how is the WHO now?].
Nakamura S
Gan To Kagaku Ryoho; 2004 Feb; 31(2):149-57. PubMed ID: 14997743
[TBL] [Abstract][Full Text] [Related]
15. Peripheral T-cell lymphomas.
Savage KJ
Blood Rev; 2007 Jul; 21(4):201-16. PubMed ID: 17512649
[TBL] [Abstract][Full Text] [Related]
16. Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: Analysis of prognosis.
Ohshima K; Karube K; Kawano R; Tsuchiya T; Suefuji H; Yamaguchi T; Suzumiya J; Kikuchii M
Int J Oncol; 2004 Sep; 25(3):605-13. PubMed ID: 15289861
[TBL] [Abstract][Full Text] [Related]
17. The aggressive peripheral T-cell lymphomas: 2015.
Armitage JO
Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
[TBL] [Abstract][Full Text] [Related]
18. Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations.
Costello R; Sanchez C; Le Treut T; Rihet P; Imbert J; Sébahoun G
Br J Haematol; 2010 Jul; 150(1):21-7. PubMed ID: 19912218
[TBL] [Abstract][Full Text] [Related]
19. Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas.
Niitsu N; Okamoto M; Nakamine H; Aoki S; Motomura S; Hirano M
Hematol Oncol; 2008 Sep; 26(3):152-8. PubMed ID: 18395866
[TBL] [Abstract][Full Text] [Related]
20. Peripheral T-cell lymphoma classification: the matter of cellular derivation.
Piccaluga PP; Agostinelli C; Tripodo C; Gazzola A; Bacci F; Sabattini E; Pileri SA;
Expert Rev Hematol; 2011 Aug; 4(4):415-25. PubMed ID: 21801133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
